EUVIMEDEUVIMED entdecken
LeserbriefOpen Access · CC BY 4.0

Use of methotrexate and TNF inhibitors in patients with rheumatoid arthritis–associated interstitial lung disease: a survey of rheumatologists

Elizabeth Park, Rabia Iqbal, Jon T Giles, Elana J Bernstein

Clinical Rheumatology · 2024-09 · 43 (9) · 3029-3032

DOI: 10.1007/s10067-024-07068-2 ↗

Kurz gefasst

Leserbrief in der Zeitschrift Clinical Rheumatology, online erschienen am 31.07.2024. Verfasst von Elizabeth Park und 3 weiteren Autor:innen. Beteiligte Einrichtung: Division of Rheumatology, Department of Medicine, Columbia University Irving Medical Center, 630 W 168thSt, P&S 3-450, New York, NY, 10032, USA. ep28…. Hauptthemen laut MEDLINE: Lung Diseases, Interstitial, Methotrexate, Arthritis, Rheumatoid, Antirheumatic Agents. Die Arbeit wurde bisher 7-mal zitiert (Crossref) und nennt 7 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: U.S. Department of Defense, NIAMS NIH HHS, NHLBI NIH HHS.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Kein Abstract verfügbar.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Lung Diseases, InterstitialMethotrexateArthritis, RheumatoidAntirheumatic AgentsHumansTumor Necrosis Factor-alphaRheumatologistsSurveys and QuestionnairesTumor Necrosis Factor InhibitorsPractice Patterns, Physicians'

Substanzen

MethotrexateAntirheumatic AgentsTumor Necrosis Factor-alphaTumor Necrosis Factor Inhibitors

Autor:innen und Institutionen

  • Division of Rheumatology, Department of Medicine, Columbia University Irving Medical Center, 630 W 168thSt, P&S 3-450, New York, NY, 10032, USA. ep2899@cumc.columbia.edu.
  • Division of Rheumatology, Department of Medicine, Columbia University Irving Medical Center, 630 W 168thSt, P&S 3-450, New York, NY, 10032, USA.
  • Division of Rheumatology, Department of Medicine, Cedars-Sinai Medical Center, Los Angeles, CA, USA.

Förderung

  • U.S. Department of Defense
  • NIAMS NIH HHS
  • NHLBI NIH HHS
  • National Institute of Arthritis and Musculoskeletal and Skin Diseases
  • National Heart, Lung, and Blood Institute

Zitieren

APA

Park, E., Iqbal, R., Giles, J. T., & Bernstein, E. J. (2024). Use of methotrexate and TNF inhibitors in patients with rheumatoid arthritis–associated interstitial lung disease: a survey of rheumatologists. Clinical Rheumatology, 43(9), 3029-3032. https://doi.org/10.1007/s10067-024-07068-2

Vancouver

Park E, Iqbal R, Giles JT, Bernstein EJ. Use of methotrexate and TNF inhibitors in patients with rheumatoid arthritis–associated interstitial lung disease: a survey of rheumatologists. Clinical Rheumatology. 2024;43(9):3029-3032. doi:10.1007/s10067-024-07068-2

BibTeX
@article{Park2024,
  author = {Park, Elizabeth and Iqbal, Rabia and Giles, Jon T and Bernstein, Elana J},
  title = {Use of methotrexate and TNF inhibitors in patients with rheumatoid arthritis–associated interstitial lung disease: a survey of rheumatologists},
  journal = {Clinical Rheumatology},
  year = {2024},
  volume = {43},
  number = {9},
  pages = {3029--3032},
  doi = {10.1007/s10067-024-07068-2}
}
Kostenlos starten →